United States: mHealth Technology – Development In An Uncertain Regulatory Climate

Last Updated: October 28 2014
Article by Jason Childress

The development and use of mobile technologies and devices is expanding at an incredibly fast pace and is changing, and in fact revolutionizing, the way patients and healthcare providers interact. Mobile medical technologies or "mHealth" technologies and applications can allow patients to better manage their own health and wellness, and provides patients and providers with greater access to patient data and information. Developers, providers, patients, hospitals and health systems and ancillary health care service providers, among many others, are rapidly creating, adopting and using varying levels of mHealth technology to improve care, outcomes and patient experiences across the diverse spectrum of health care delivery. However, existing in a highly regulated space may prove to be a challenge for mHealth technology developers and entrepreneurs. Developers will need to determine how, and if, a wide array of laws and regulations apply to their technology, and how to comply with the applicable regulations. Examples of laws, issues and regulations that developers should give consideration to, include, but are not limited to, the Health Insurance Portability and Accountability Act (HIPAA), various individual State data protection and privacy laws, regulations impacting reimbursement, and the oversight, classification and registration requirements of the U.S. Food and Drug Administration (FDA).

The task of determining which laws and regulations apply to new mHealth technologies may prove to be a challenge (and an expense) in that regulators and agencies are working within the boundaries of laws and regulations that were not necessarily designed for the current, ever developing and changing technological world. While the FDA and regulatory agencies are looking at these regulatory issues, questions still remain as what regulations apply to mHealth technologies. For example, queries may exist, depending upon the mHealth technology in question, as to how HIPAA applies to the collection and use of sensitive personal data. mHealth technologies that utilize new manners of data collection and storage, encryption measures, and that contain restrictions on who can access data, raise questions as to how HIPAA's requirements apply and how such requirements may be complied with. Additionally, and as evidence of the uncertainty of the application of regulations, trade groups and entities have sought guidance from the FDA on, and have even urged Congress to create legislation clarifying, which mHealth technologies are, and which are not, subject to FDA oversight.

The FDA initially addressed this issue via the "Mobile Medical Applications Guidance for Industry and Food and Drug Administration Staff" issued in September of 2013 (the Final Guidance). The FDA stated its intent take a hands off approach to certain mHealth technologies that pose little to no threat to patient safety, and stated that it is reserving oversight to "mobile medical applications," The Final Guidance defined "mobile medical applications" as a mobile application that meets the definition of device under Section 201(h) of the Federal Food Drug and Cosmetic Act (FD&C Act) and which is either intended: (i) to be used as an accessory to a regulated medical device, or (ii) to transform a mobile platform into a regulated medical device. The FDA stated that the intend use of the mobile application (or "app") determines if the app meets the definition of a "device" under the FD&C Act.

The FDA regulates mobile medical apps using the same classification standards it uses for regulated medical devices, with such classification system using a risk based approach. Medical devices are classified as a Class I, Class II or Class III device, with regulatory control and oversight increasing from Class I to Class III. Device classification defines the regulatory requirements for a device type (for example, most Class II devices require a Premarket Notification – 510(k), while most Class III devices require a Premarket Approval).

While the FDA recognizes that many mobile medical apps may meet the regulatory definition of a "device", it recognizes that many may pose minimal to no risk to patients. For such apps the FDA states it will exercise enforcement discretion and will not expect developers to submit premarket review applications or register and list their apps with the FDA. Seemingly following this same principle, the FDA issued a new draft guidance in June 2014 entitled "Medical Device Data Systems, Medical Image Storage Devices, and Medical Image Communications Devices- Draft Guidance for Industry and Food and Drug Administration Staff (Draft Guidance). The Draft Guidance informs developers that the FDA does not intend to enforce compliance with the regulatory controls that apply to medical device data systems (MDDS), medical image storage devices, and medical image communications devices, due to the low risk they pose to patients and the importance they play in advancing digital health. The FDA down-classified MDDS from a Class III device to a Class I device. With this change, the FDA proposed edits to the Final Guidance to conform to the Draft Guidance.

Most recently, in October 2014, the FDA finalized recommendations in a guidance document for medical device manufactures for managing cybersecurity risks to better protect patients' safety and health information. In the guidance the FDA identifies concerns about cybersecurity vulnerabilities. The guidance is intended to supplement the FDA's "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices," and applies to premarket submissions for devices that contain software or programmable logic as well as software that is a medical device. Developers of mobile medical apps subject to FDA oversight and review should also comply, as applicable, with the newly issued guidance.

The continued issuance of guidance documents by the FDA, and outcries for clarifying legislation and guidance by industry highlights potential regulatory hurdles developers of mHealth technologies may face in bringing technologies to market. Developers should be cautious and take care to ascertain what regulations and laws may apply to the contemplated technologies, and should work to ensure the developed technology complies appropriately.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
McDermott Will & Emery
Akin Gump Strauss Hauer & Feld LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
McDermott Will & Emery
Akin Gump Strauss Hauer & Feld LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions